Templeton Emerging Markets Fund
EMF · NYSE
8/31/2025 | 8/31/2024 | 8/31/2023 | 8/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.06 | 0.08 | -0.10 | 0.01 |
| FCF Yield | 0.00% | 0.00% | 0.00% | 0.00% |
| EV / EBITDA | 4.63 | 6.94 | 12.08 | -2.53 |
| Quality | ||||
| ROIC | 1,015.78% | 11.58% | 7.08% | -31.42% |
| Gross Margin | 78.69% | 100.00% | 74.66% | 103.84% |
| Cash Conversion Ratio | – | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | 8.61% | – | -43.20% | – |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 0.11 | 0.17 | 0.62 | -0.29 |
| Interest Coverage | 0.00 | 82.21 | 26.92 | -234.68 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 49.25 | 11.09 | -119.05 | -39.43 |